Serum S100B Protein Could Help to Detect Cerebral Complications Associated with Extracorporeal Membrane Oxygenation (ECMO)

详细信息    查看全文

• 作者：Duc Nam Nguyen (1)
  Luc Huyghens (1)
  Francis Wellens (2)
  Johan Schiettecatte (3)
  Johan Smitz (3)
  Jean-Louis Vincent (4)
  
• 关键词：ECMO ; S100B protein ; Cerebral complications
• 刊名：Neurocritical Care
• 出版年：2014
• 出版时间：June 2014
• 年：2014
• 卷：20
• 期：3
• 页码：367-374
• 全文大小：
• 参考文献：1. Marasco SF, Lukas G, McDonald M, McMillan J, Ihle B. Review of ECMO (extracorporeal membrane oxygenation) support in critically ill adults patients. Heart Lung Circ. 2008;17S:S41-. CrossRef
  2. Hervey-Jumper SL, Annich GM, Yancon AR, Garton HJ, Murasszko KM, Maher CO. Neurological complications of extracorporeal membrane oxygenation in children. J Neurosurg Pediatr. 2011;7:338-4. CrossRef
  3. Mateen FJ, Muralidharam R, Shinohara RT, Parisi JE, Schears GJ, Wijdicks EF. Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol. 2011;68:1543-. CrossRef
  4. Short BL. The effect of extracorporeal life support on the brain: a focus on ECMO. Semin Perinatol. 2005;29:45-0. CrossRef
  5. Risnes I, Wagner K, Nome T, Sundet K, Jensen J, Hynas IA, Ueland T, Pedersen T, Svennevig JL. Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation. Ann Thorac Surg. 2006;81:1401-. CrossRef
  6. McLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure life support in the new era. Intensive Care Med. 2012;38:210-0. CrossRef
  7. Girard TD, Panharipande PP, Ely W. Delirium in the intensive care unit. Crit Care. 2008;12(suppl 3):S3. CrossRef
  8. Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinskka EB. The neuroinflammatory hypothesis of delirium. Acta Neuropathol. 2010;119:737-4. CrossRef
  9. Janz DR, Abel TW, Jackson JC, Gunther ML, Heckers S, Wesley E. Brain autopsy findings in intensive care unit patients previously suffering from delirium: a pilot study. J Crit Care. 2010;25:538e7-2. CrossRef
  10. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Fran?oise G. The neuropathology of septic shock. Brain Pathol. 2004;14:21-3. CrossRef
  11. Muralidharan R, Mateen FJ, Shinohara RT, Schears GJ. The challenges with brain death determination in adult patients on extracorporeal membrane oxygenation. Neurocrit Care. 2011;14:423-. CrossRef
  12. Chow FC, Edlow BL, Frosch MP, Copen WA, Greer DM. Outcome in patients with H1N1 influenza and cerebrovascular injury treated with extracorporeal membrane oxygenation. Neurocrit Care. 2011;15:156-0. CrossRef
  13. Gazzolo D, Masetti P, Grutzfeld D, Michetti F. Elevated S100B protein as an early indicator of intracranial hemorrhage in infants subjected to extracorporeal membrane oxygenation. Acta Pediatr. 2002;91:218-1. CrossRef
  14. Townend W, Ingebrigtsen T. Head injury outcome prediction: a role for protein S-100B? Injury. 2006;37:1098-08. CrossRef
  15. Sen J, Belli A. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res. 2007;85(7):1373-0. CrossRef
  16. Song KJ, Shin SD, Ong ME, Jeong JS. Can early serum levels of S100B protein predicts the prognosis of patients with out-of-hospital cardiac arrest. Resuscitation. 2010;81:337-2. CrossRef
  17. Van Munster BC, Korse CM, de Rooij SE, Bonfrer JM, Zwinderman AH, Korevaar JC. Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol. 2009;9:21. CrossRef
  18. Linstedt U, Meyer O, Kropp P, Berkau A, Zenz M. Serum concentration of S-100 protein in assessment of cognitive dysfunction after general anesthesia in different types of surgery. Acta Anaesthesiol Scand. 2002;46:384-. CrossRef
  19. Nguyen DN, Spapen H, Su F, Schiettecatte J, Shi L, Hacimi-Idrissi S, Huyghens L. Elevated serum levels of S-100B protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med. 2006;34:1967-4. CrossRef
  20. Conti A, Lacopino DG, Spada A, Cardall SM, Giusa N, La Torre D, Campenni A, Penna O, Baldari S, Tomasello F. Transcranial Doppler ultrasonography in the assessment of cerebral circulatory arrest: improving sensitivity by transcervical and transorbital carotid insonation and serial examinations. Neurocrit Care. 2009;10:326-5. CrossRef
  21. Karasirajan V, Smedira NG, McCarthy JF, Casselman F, Boparai N, McCarthy PM. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 1999;15:508-4. CrossRef
  22. Heuer JF, Pelosi P, Hermann P, Perske C, Crozier TA, Brück W, Quintel M. Acute effects of intracranial hypertension and ARDS on pulmonary and neuron damage: a randomized experimental study in pigs. Intensive Care Med. 2011;37:1182-1. CrossRef
  23. Jarjour IT, Ahbad-Barmada M. Cerebrovascular lesions in infants and children dying after extracorporeal membrane oxygenation. Pediatr Neurol. 1994;10:13-. CrossRef
  24. Biehl DA, Stewart DL, Forti NH, Cook LN. Timing of intracranial hemorrhage during extracorporeal life support. ASAIO J. 1996;42:938-1. CrossRef
  25. Lidegran MK, Mosskin M, Ringertz HG, Bj?rn P, Freckner BP, Linden VB. Cranial CT for diagnosis of intracranial complications in adult and pediatric patients during ECMO: clinical benefits in diagnosis and treatment. Acad Radiol. 2007;14:62-1. CrossRef
  26. David L, Bellolio F. S100 as a marker of acute brain ischemia. Neurocrit Care. 2008;8:301-. CrossRef
  27. Raabe A, Kopetsch O, Woszczyk A, Lang J, Gerlach R, Zimmermann M, Seifert V. S100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurol Res. 2004;24:440-. CrossRef
  28. Georgiadis D, Berger A, Kowatschev E, Lautenschl?ger C, B?rner A, Lindner A, Schulte-Mattler W, Zerkowski HR, Zierz S, Deufel T. Predictive values of S100B and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg. 2000;119:138-7. CrossRef
  29. Ueno T, Iguro Y, Yamamoto H, Sakata R, Kakihana Y, Nakamura K. Serial measurement of serum S100B protein as a marker of cerebral damage after cardiac surgery. Ann Thorac Surg. 2003;75:1892-. CrossRef
  30. Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci. 2003;21:97-08.
  31. Ohrt-Nissen S, Friis-Hansen L, Dahl B, Stensballe J, Rommer B, Rasmussen LS. How does extracerebral trauma affect the clinical values of S100B measurement. Emerg Med J. 2011;28:941-. CrossRef
  32. Pelinka LE, Harada N, Szalay L, Jafarmadar M, Redl H, Bahrami S. Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock. 2001;21:72-. CrossRef
  33. Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, Janigro D. Extracranial sources of S100B do not affect serum levels. PLoS ONE. 2010;5:e12691. CrossRef
  34. Yokota H, Ogawa S, Kukokawa A, Yamamoto Y. Regional cerebral blood flow in delirium patients. Psychiatry Clin Neurosci. 2003;57:337-. CrossRef
  
• 作者单位：Duc Nam Nguyen (1)
  Luc Huyghens (1)
  Francis Wellens (2)
  Johan Schiettecatte (3)
  Johan Smitz (3)
  Jean-Louis Vincent (4)
  
  1. Department of Critical Care, University Hospital of Brussels, Laarbeeklaan 101, 1090, Brussels, Belgium
  2. Department of Cardiac Surgery, University Hospital of Brussels, Brussels, Belgium
  3. Department of Radioimmunochemistry, University Hospital of Brussels, Brussels, Belgium
  4. Department of Intensive Care, Erasme University Hospital, Brussels, Belgium
  
• ISSN：1556-0961

文摘

Background To investigate if serum S100B protein levels could early detect cerebral complications under treatment extracorporeal membrane oxygenation (ECMO). Methods Serum S100B levels were measured over 5?days in 32 patients with cardiogenic and septic shock, including 15 patients who treated by ECMO and 17 who did not. Cerebral complications included hemorrhage, stroke, encephalopathy with myoclonus, and brain death. Delirium was identified by the positive Confusion Assessment Method in the ICU. Results S100B levels were elevated in 24/32 patients (75?%) at ICU admission. Five patients developed cerebral complications (2 hemorrhages with 1 brain death, 1 encephalopathy with myoclonus in the ECMO group and 2 strokes in the non-ECMO group). At day 5, S100B levels were higher in the 5 patients with cerebral complications than in the 27 without cerebral complications, regardless of ECMO (0.426 [0.421, 0.652] vs. 0.102 [0.085, 0.135] μg/L, p?=?0.011). S100B levels were also more elevated in 3 patients with than in 12 without cerebral complications associated with ECMO (0.799 [0.325, 0.965] vs. 0.102 [0.09, 0.607] μg/L, p?=?0.033). S100B levels were not associated with delirium after sedation withdrawal. Conclusions Measurement serum S100B could be useful to detect cerebral complications in deeply sedated patients associated with ECMO but not for monitoring delirium after sedation withdrawal.